User profiles for Thomas Deloughery

Thomas DeLoughery

Professor of Medicine, Pathology,and Pediatrics
Verified email at ohsu.edu
Cited by 7557

[HTML][HTML] Current and potential imaging applications of ferumoxytol for magnetic resonance imaging

…, R Barajas, JS Cetas, J Ciporen, TJ DeLoughery… - Kidney international, 2017 - Elsevier
Contrast-enhanced magnetic resonance imaging is a commonly used diagnostic tool.
Compared with standard gadolinium-based contrast agents, ferumoxytol (Feraheme, AMAG …

Iron deficiency anemia

TG DeLoughery - Medical Clinics, 2017 - medical.theclinics.com
Iron deficiency anemia is the most common and most treatable of all anemias. There is an
evolving understanding that iron deficiency can lead to symptoms independent of anemia and …

[HTML][HTML] Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies

…, OJT McCarty, AV Danilov, TG DeLoughery - Journal of thrombosis …, 2017 - Elsevier
Ibrutinib is an irreversible inhibitor of Bruton's tyrosine kinase (Btk) that has proven to be an
effective therapeutic agent for multiple B‐cell‐mediated lymphoproliferative disorders. …

Microcytic anemia

TG DeLoughery - New England Journal of Medicine, 2014 - Mass Medical Soc
Microcytic anemia is characterized by smaller-than-normal red cells due to decreased
production of hemoglobin. This review discusses diagnosis and treatment of thalassemia …

Common mutation in methylenetetrahydrofolate reductase: correlation with homocysteine metabolism and late-onset vascular disease

TG Deloughery, A Evans, A Sadeghi, J McWilliams… - Circulation, 1996 - Am Heart Assoc
Background Increased homocysteine levels are a risk factor for atherosclerosis and its
sequelae. A common genetic mutation in methylenetetrahydrofolate reductase (MTHFR), an …

[HTML][HTML] Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis

…, SE Moseley, GJ Landry, TG DeLoughery… - Journal of vascular …, 2012 - Elsevier
OBJECTIVES: Peripherally inserted central catheters (PICCs) may be complicated by upper
extremity (UE) superficial (SVT) or deep venous thrombosis (DVT). The purpose of this study …

Thrombosis and bleeding in extracorporeal membrane oxygenation (ECMO) without anticoagulation: a systematic review

…, AD Meyer, OJT Mccarty, TG Deloughery… - ASAIO …, 2021 - journals.lww.com
Extracorporeal membrane oxygenation (ECMO) causes both thrombosis and bleeding. Major
society guidelines recommend continuous, systemic anticoagulation to prevent thrombosis …

Simultaneous onset of COVID‐19 and autoimmune haemolytic anaemia

…, A Pandey, T Huang, TG DeLoughery - British journal of …, 2020 - ncbi.nlm.nih.gov
1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of
adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020…

The many roles of tranexamic acid: an overview of the clinical indications for TXA in medical and surgical patients

…, H Al‐Samkari, TG DeLoughery… - European journal of …, 2020 - Wiley Online Library
Clinically significant bleeding can occur as a consequence of surgery, trauma, obstetric
complications, anticoagulation, and a wide variety of disorders of hemostasis. As the causes of …

The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis

…, JJ Shatzel, JH Jou, TG Deloughery - European journal of …, 2017 - Wiley Online Library
Introduction The coagulopathy of cirrhosis is complex, placing patients at risk for both bleeding
and thrombosis. Direct oral anticoagulants ( DOAC s) have equivalent or superior efficacy …